IP Library Granted Patent US 11,155,851
Granted Patent B2
US 11,155,851 · App. 15/188,239 · Granted Oct 26, 2021

Compounds and methods relating to lysosomal storage disorders

Inventors: Alexander Cherkassky (Wayland, MA); Jason Coumoyer (Jamaica Plain, MA); Michael Gelb (Seattle, WA)
Assignees: University of Washington through its Center for Commercialization; PerkinElmer Health Sciences, Inc.
C12Q1/34C07C233/18C07H15/10G01N2333/924
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,155,851
App. No.
15/188,239
Granted
Oct 26, 2021
Kind
B2
Abstract

Methods are provided for detecting enzymatic activity of various lysosomal storage enzymes using substrates that include: a sugar moiety; a linker moiety allowing the conjugation of sugar moiety with the remaining structure of the substrate; and two or more fatty acid chains or derivatives thereof at least one of which is sufficiently structured to provide improved solubility in aqueous or organic solvent systems. Also provided are internal standards, and inhibitors for use in detecting or reducing enzymatic activity using the inventive substrates.

Claims (20)

1. A method for detecting enzymatic activity, comprising:

contacting a sample containing a target enzyme with a composition comprising a first substrate and a second substrate, under conditions wherein the target enzyme is capable of acting on the first substrate or the second substrate to produce an enzymatic product; and

detecting said enzymatic product;

the first substrate having the formula:

where A is a galactose linked to O by a glycosidic bond;

B1 is selected from the group consisting of: a C 1 -C 20 alkyl; a heteroatom containing C 1 -C 20 alkyl; C 2 -C 20 alkenyl; a heteroatom containing C 2 -C 20 alkenyl; and a substituted or unsubstituted C 6 -C 20 aryl;

B2 is selected from the group consisting of: a C 2 -C 7 urethane; a C 2 -C 7 amido; a C 2 -C 7 ester; a C 2 -C 7 uriedo; a C 2 -C 7 carbamato; a C 2 -C 7 carbonyl; a C 1 -C 7 alkyl; a heteroatom containing C 1 -C 7 alkyl; a C 1 -C 7 alkyl having a substituent of N, O, or S; a C 2 -C 7 alkenyl; a heteroatom containing C 2 -C 7 alkenyl; and a C 2 -C 7 alkenyl having a substituent of N, O, or S; and

B3 is selected from the group consisting of: a C 1 -C 20 alkyl; a heteroatom containing C 1 -C 20 alkyl; C 1 -C 20 alkyl having a substituent of N, O, or S; C 4 -C 20 ether; C 1 -C 20 ester; C 1 -C 20 alkenyl; a heteroatom containing C 1 -C 20 alkenyl; C 2 -C 20 alkenyl having a substituent of N, O, or S; C 1 -C 20 alkynl; a heteroatom containing C 1 -C 20 alkynl; C 2 -C 20 alkynl having a substituent of N, O, or S; C 6 -C 20 aryl; and a C 6 -C 20 heterocyclic containing a heteroatom of N, O or S; and

the second substrate having the formula:

2. The method of claim 1 wherein said target enzyme is acid galactocerebroside β-galactosidase or acid-β-glucocerebrosidase and said wherein said B2 is a C 2 -C 7 amido, and B3 is a C 13 -C 20 having a substituent of O present as a hydroxyl.

3. The method of claim 1 wherein A is a a D-galactose.

4. The method of claim 1 wherein B1 is a methylene.

5. The method of claim 1 where B2 is a C 2 -C 7 amido.

6. The method of claim 1 wherein B3 is a C 2 -C 20 alkenyl having a substituent of N, O, or S.

7. The method of claim 1 wherein: A is a D-galactose; B1 is a C 1 -C 2 alkyl or a C 6 aryl; and B2 is a C 2 -C 7 amido.

8. The method of claim 7 wherein B3 is a C 2 -C 20 alkenyl having a substituent of N, O, or S.

9. The method of claim 1 wherein the first substrate comprises:

where: A is galactose; R 1 is a C 1 -C 6 alkyl or a C 2 -C 6 alkenyl; and R 2 is a C 1 -C 20 alkyl, a C 1 -C 20 alkyl having a substituent of N, O, or S, a C 1 -C 20 alkenyl, or a C 1 -C 20 alkenyl having a substituent of N, O or S.

10. The method of claim 9 wherein A is a D-galactose, R 1 is a C 4 -C 6 alkyl, and R 2 is a C 13 -C 20 alkyl, a C 13 -C 20 alkyl having a substituent of N, O, or S, a C 13 -C 20 alkenyl, or a C 13 -C 20 alkenyl having a substituent of N, O or S.

11. The method of claim 9 wherein R 2 is a C 13 alkyl.

Assignments (3)
CHANGE OF NAME Recorded Mar 25, 2024
From: PERKINELMER HEALTH SCIENCES, INC.
To: REVVITY HEALTH SCIENCES, INC.
Reel/Frame 067006/0297 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2016
From: GELB, MICHAEL
To: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
Reel/Frame 039100/0748 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2016
From: CHERKASSKY, ALEXANDER; COURNOYER, JASON
To: PERKINELMER LIFE SCIENCES, INC.
Reel/Frame 039100/0863 →